DNDi - NewsLetter


HOME
ABOUT DNDi EDITORIAL: "Key Challenges for Successful Partnerships" CALENDAR HOW YOU CAN HELP DNDi?
DNDi's Malaria Project: A Model for Innovative Partnerships? Fighting Malaria in the Legal Amazon, Brazil ASMQ in a Nutshell ASAQ: a new Business Model for a "Big Pharma" ASMQ: a Great Public-Private, Intercontinental Partnership Why Lead Platforms are Crucial to Boost Innovation for Neglected Diseases Asian Region Makes Use of its Biodiversity to Identify New Bioactive Molecules Our moral responsibility to address Public Health Issues Four Characteristics For Partnership Paving the Way to Win-Win Partnerships DNDi R&D Projects-2008 Outlook Synergise Efforts with Anacor, GSK, IRD, Eskitis, UNC, and Intitut Pasteur Korea. Operational Challenges: Clinical Trial Partnerships in Africa LEAP: 4 Years and Going Strong... Concentrated HAT Platform Efforts in the 5 Most Affected Countries Advances at the DNDi Regional Support Office KEMRI, Nairobi Actions to Increase Awareness and Visibility in the Asian Region DNDi's Launch of ASMQ in Rio de Janeiro DNDi Project Collaboration in Japan DNDi in DRC brings Regular Support to the Clinical Trials From Discovery to Clinical Trials in India DNDi Strengthens North American Presence DNDi Joins Scientists Without Borders^SM Fexinidazole: A Rediscovered Compound Progresses as a Preclinical Drug Candidate for HAT Neglected by Everybody: PLoS NTD Publishes Media Analysis on Neglected Diseases DNDi Participates at International Meeting on Chagas Disease DNDi Awarded by the French Societé de Pathologie Exotique DNDi Receives Goodwin Award for Its Social Entrepeneurial Approach for the Most Neglected Diversifying Sources of Funding News from Donors IGWG: An Important Step Towards Boosting Innovation Contact DNDi

ABOUT DNDi

Mission Statement

The Drugs for Neglected Diseases initiative (DNDi) is an independent, not-for-profit Product Development Partnership working to research and develop new and improved treatments for neglected diseases such as malaria, leishmaniasis, sleeping sickness, and Chagas disease. DNDi was founded in 2003 by four publicly-funded research institutes from Malaysia, India, Kenya and Brazil along with Institut Pasteur and MSF.

Published by Drugs for Neglected Diseases Initiative - 15 Chemin Louis-Dunant 1202 Geneva Switzerland - Photo credits: DNDi unless otherwise stated - Editor: Sadia Kaenzig - Tel: +41 22 906 9230 - Fax: +41 22 906 9231 - www.dndi.org